PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy
- Citation:
- Cancer Res vol 72 (24 supplement) abstract P2-10-01
- Meeting Instance:
- AACR 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Parents:
- None
- Children:
- 2088
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. Liu B. Pitcher E. Mardis S. Davies J. Snider T. Vickery J. Reed K. Deschryver B. Singh P. Friedman W. Gradishar E. Perez S. Martino M. Citron L. Norton E. Winer C. Hudis C. Perou M. Ellis W. Barry
- Networks:
- Study
- CALGB-9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: